Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Aethlon Medical, Inc. (AEMD)

NCM · Medical Devices

$0.56+0.00 (+0.12%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.5M
P/E (TTM)
EPS
$-10.62
Div Yield
52W Range
$0.54–$27.40
Beta
1.41

Company overview

Next earnings: 2026-08-12(15d)

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Peers in Medical Devices

All in industry →

Recent press releases

Aethlon Medical, Inc. has not issued a press release in this window.

SEC filings

All filings →

Aethlon Medical, Inc. has not filed an SEC document in this window.

Aethlon Medical, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-06-30
1 sh● NEW

People at Aethlon Medical, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
12/24
NI -$1.8M
06/25
NI -$1.8M
09/25
NI -$1.5M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-3.74
Prior: $-0.85
Revenue sparkline